Biophotonics Market Rising at 11.5% CAGR of to 2020 Impelled By Emergence of Nanotechnology

Nov 23, 2015, 05:00 ET from RnR Market Research

PUNE, India, November 23, 2015 /PRNewswire/ --

The global biophotonics market report for 2015 to 2020 categorizes the industry on the basis of application, technology, end use, and geography as well as forecasts the market size and analyzes trends in the said market.

Complete report on biophotonics market spread across 156 pages, profiling 10 major companies and supported with 80 tables and 50 figures is now available at http://www.rnrmarketresearch.com/biophotonics-market-by-medical-applications-bioimaging-bioassays-optical-biosensors-and-biochips-medical-devices-non-medical-applications-biometric-and-biosensing-devices-uv-sterilization-equipment-and-regions-global-forecast-market-report.html .

The worldwide biophotonics market is expected to reach USD 50.18 billion by 2020, at a CAGR of 11.5% between 2015 and 2020. The industry has witnessed tremendous technological improvements over the past few years. Major drivers identified for the growth of the biophotonics market are emergence of nanotechnology, significant technological advancements over the last few years, and increase in the demand for home-based POC devices, and increasing population & growing lifestyle diseases. Major restraints are slow rate of commercialization, high cost involved in research and development, and reluctance toward the adoption of new treatment practices.

Surface imaging market is expected to grow at higher CAGR during the forecast period. The application in see-through imaging accounted for the largest market share of the total biophotonics market. However, the market for surface imaging is expected to grow at the highest CAGR between 2015 and 2020. Medical diagnostics has emerged as a largest market segment for biophotonics market in 2014. The biophotonics market in the following geographic regions has been included in the report - the Americas, Europe, Asia-Pacific, and Rest of the World (RoW). Out of these regions America's biophotonics market is expected to grow at a highest CAGR during the forecast period.

During this biophotonics market study several interviews were conducted with industry leaders such as CEOs, VPs, directors, and marketing executives for key insights. Break-up of profile of primary participants for the report is as given below:

  • By Company Type - Tier 1 - 35 %, Tier 2 - 40% and Tier 3 - 25%
  • By Designation - C level - 35%, Director level - 25%, Others - 40%
  • By Region - Americas - 43%, Europe - 19%, APAC - 29%, RoW - 9%

This report takes a close look at the biophotonics market, providing a holistic outlook on market dynamics, industry trends, and supply & demand. The study aims at providing granular information regarding estimates and forecasts for the biophotonics market segments. This report is based on an extensive research study of the biophotonics market and aims at identifying the entire market and all its sub-segments through extensively detailed classifications. The demand for biophotonics is expected to grow significantly and gain importance among players across various domains. The Americas is projected to be the fastest-growing market during the forecast period.

Key players profiled in this report include Affymetrix, Inc. (U.S.), Andor Technology Ltd. (U.K.), Becton, Dickinson and Company (U.S.), Carl Zeiss AG (Germany), FEI Company (U.S.), Hamamatsu Photonics K.K. (Japan), Lumenis Ltd. (Israel), Olympus Corporation (Japan), PerkinElmer, Inc. (U.S.), and Zecotek Photonics Inc. (Canada). Order a copy of Biophotonics Market by Application (See-through Imaging, Inside Imaging, Spectromolecular, Surface Imaging, Microscopy, Light Therapy, Biosensors), Technology (In-vivo, In-vitro), End-use(Diagnostics, Therapeutic, Tests), & Geography - Global Forecast to 2020 research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=430305 .

On related lines, another research on Biosimulation Market Global Forecast to 2020 says the market growth is majorly driven by the availability of R&D investments in biotechnology and pharmaceutical industries. The global biosimulation market is expected to reach USD 2,107.99 million by 2020 from USD 1,034.93 million in 2015, at a CAGR of 15.29% between 2015 and 2020. Companies like Certara USA, Inc, Simulation Plus Inc., Dassault Systèmes SA, Schrödinger Inc., Advanced Chemistry Development, Inc. and others are also discussed in this research report available at http://www.rnrmarketresearch.com/biosimulation-market-by-product-software-molecular-modeling-pb-pk-pkpd-trial-design-toxicity-prediction-in-house-contract-service-application-drug-discovery-development-preclinical-clinical-trial-by-end-users-global-forecast--market-report.html .

About Us:   

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
sales@rnrmarketresearch.com


SOURCE RnR Market Research